Evaluation of the Therapeutic Efficacy of Sequential Therapy Involving Percutaneous Microwave Ablation in Combination with 131I-Hypericin Using the VX2 Rabbit Breast Solid Tumor Model

Abstract

PurposeCombination of percutaneous microwave ablation (PMWA) and intravenous injection of 131I-hypericin(IIIH) may bear potential as a mini-invasive treatment for tumor. The objective of this study was to assess the effect of PMWA and IIIH in breast tumor growth.MethodsTen New Zealand White rabbits bearing VX2 breast carcinomas were randomly divided into two groups (each 5 examples) and processed using PMWA followed by IIIH and IIIH alone. The IIIH activity was evaluated using planar scintigraphy, autoradiography and biodistribution analysis. The maximum effective safe dose of IIIH was found through 48 rabbits with VX2 breast tumor, which were randomized into six groups (n=8 per group). Subsequently, a further 75 rabbits bearing VX2 breast solid tumors were randomly divided into five groups (each 15 examples) and treated as follows: A, no treatment group; B, PMWA alone; C, IIIH alone; D, PMWA+IIIH×1 (at 8 h post-PMWA); and E, PMWA+IIIH×2 (at 8 h and at 8 days post-PMWA). The therapeutic effect was assessed by measurement of tumor size and performation of positron emission tomography/computed tomograph (PET/CT) scans, liver and renal function tests and Kaplan-Meier survival analysis.ResultsThe planar scintigraphy findings suggested a significant uptake of 131I in necrotic tumor tissue. The autoradiography gray scales indicated higher selective uptake of IIIH by necrotic tissue, with significant differences between the groups with and those without necrotic tumor tissue (P<0.05). The maximum effective safe dose of IIIH was 1mCi/kg. The PET/CT scans and tumor size measurement suggested improvements in treatment groups at all time points (P<0.01). Significant differences were detected among Groups A, B, D and E (P<0.05). Lower levels of lung metastasis were detected in Groups D and E (P<0.05). There were no abnormalities in liver and renal functions tests or other reported side effects.ConclusionIIIH exhibited selective uptake by necrotic tumor tissue. Sequential therapy involving PMWA+IIIH was successfully inhibiting tumor growth and prolonging survival.

Ultrasound-guided percutaneous microwave ablation for benign breast lesions: evaluated by contrast-enhanced ultrasound combined with magnetic resonance imaging

“…Currently, MWA has been explored in clinical practice, which destroys tumors in situ by means of thermal coagulation or protein denaturation (10). Several studies reported successful experience in the treatment of small breast cancer by using MWA (11,12).…”

Updated developments on molecular imaging and therapeutic strategies directed against necrosis

“…Apart from its potential for imaging necrotic myocardium after labeled with iodine-12354., 55., 56., Hyp had also been extensively explored for the treatment of diverse solid tumors or evaluation of therapeutic efficacy after labeled with iodine-131 or copper-64 (Fig. 1)57., 58., 59., 60., 61., 62., 63., 64., 65.. Despite the substantial translational potential related to certain oncological and non-oncological applications 66 , some inherent defects such as extremely poor water solubility, easy to form aggregates and deep colors may haunt its further clinical transformation.…”

Targeted Phototherapy by Niobium Carbide for Mammalian Tumor Models Similar to Human Being

“…Better than mice model, rabbits are more suitable to establish the orthotopically xenografted tumor and the tumor could also be larger. To sum up, orthotopic tumors on rabbits are more similar to the clinical human tumor [15]. However, the fast development of tumor and high-rate of tumor recurrence on rabbits hinders the phototherapy from big animal modal.…”